FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 3053588 · Received April 11, 2013

Report

Report Number
2124215-2013-05200
Event Type
Malfunction
Date Received
April 11, 2013
Date of Event
March 25, 2013
Report Date
March 25, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING THE PACEMAKER REPLACEMENT PROCEDURE, WHEN THIS RIGHT ATRIAL (RA) LEAD WAS CONNECTED TO THE HEADER BLOOD WAS OBSERVED. WHEN TESTED, THE LEAD EXHIBITED IMPEDANCE MEASUREMENTS GREATER THAN 2,000 OHMS. THE LEAD WAS REPROGRAMMED TO A UNIPOLAR CONFIGURATION AND IMPEDANCES DECREASED TO AN ACCEPTABLE RANGE. THE LEAD REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156494 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4473

Patients

Seq Age Sex Outcome Treatment
1 77 YR 4473| K063| 4474| 1290